ATA677478A - Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten - Google Patents

Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten

Info

Publication number
ATA677478A
ATA677478A AT0677478A AT677478A ATA677478A AT A677478 A ATA677478 A AT A677478A AT 0677478 A AT0677478 A AT 0677478A AT 677478 A AT677478 A AT 677478A AT A677478 A ATA677478 A AT A677478A
Authority
AT
Austria
Prior art keywords
prostacycline
derivatives
producing new
including complexes
new cyclodextrin
Prior art date
Application number
AT0677478A
Other languages
English (en)
Other versions
AT369362B (de
Inventor
Jozsef Dr Dipl Ing Szejtli
Magdolna Dr Szejtli
Gyoergy Dr Cseh
Istvan Dr Stadler
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of ATA677478A publication Critical patent/ATA677478A/de
Application granted granted Critical
Publication of AT369362B publication Critical patent/AT369362B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT0677478A 1977-09-23 1978-09-20 Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten AT369362B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (de) 1977-09-23 1977-09-23

Publications (2)

Publication Number Publication Date
ATA677478A true ATA677478A (de) 1982-05-15
AT369362B AT369362B (de) 1982-12-27

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0677478A AT369362B (de) 1977-09-23 1978-09-20 Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten

Country Status (20)

Country Link
JP (1) JPS5456685A (de)
AT (1) AT369362B (de)
BE (1) BE870646A (de)
CH (1) CH637388A5 (de)
CS (1) CS200242B2 (de)
DD (1) DD138600A5 (de)
DE (1) DE2840142A1 (de)
DK (1) DK420778A (de)
FI (1) FI65912C (de)
FR (1) FR2404006A1 (de)
GB (1) GB2006193B (de)
GR (1) GR65001B (de)
HU (1) HU179141B (de)
IL (1) IL55569A (de)
IT (1) IT1160661B (de)
NL (1) NL7809643A (de)
PL (1) PL121664B1 (de)
SE (1) SE447574B (de)
SU (1) SU847914A3 (de)
YU (1) YU220678A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
CN101497595A (zh) 2004-01-29 2009-08-05 卫材R&D管理有限公司 大环内酯类化合物的稳定化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (de) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
IL55569A0 (en) 1978-12-17
YU220678A (en) 1983-10-31
GB2006193A (en) 1979-05-02
DE2840142A1 (de) 1979-04-05
CS200242B2 (en) 1980-08-29
SU847914A3 (ru) 1981-07-15
IT1160661B (it) 1987-03-11
SE447574B (sv) 1986-11-24
HU179141B (de) 1982-08-28
GR65001B (en) 1980-06-12
GB2006193B (en) 1982-05-26
FI782878A (fi) 1979-03-24
DD138600A5 (de) 1979-11-14
FR2404006A1 (fr) 1979-04-20
PL209773A1 (pl) 1979-06-04
NL7809643A (nl) 1979-03-27
PL121664B1 (en) 1982-05-31
DK420778A (da) 1979-03-24
BE870646A (fr) 1979-01-15
JPS5456685A (en) 1979-05-07
IL55569A (en) 1981-12-31
FR2404006B1 (de) 1981-07-31
CH637388A5 (de) 1983-07-29
SE7809946L (sv) 1979-03-24
AT369362B (de) 1982-12-27
FI65912C (fi) 1984-08-10
FI65912B (fi) 1984-04-30
IT7869160A0 (it) 1978-09-19

Similar Documents

Publication Publication Date Title
AT341518B (de) Verfahren zur herstellung von neuen imidazolderivaten und ihren salzen
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
DD134088A5 (de) Verfahren zur herstellung von neuen pyrrolidinderivaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
ATA677478A (de) Verfahren zur herstellung von neuen cyclodextrin- einschlusskomplexen des prostacyclins und dessen derivaten
ATA870975A (de) Verfahren zur herstellung von neuen 4-hydroxy- hydroxyindol-derivaten und ihren salzen
AT374183B (de) Verfahren zur herstellung von neuen carbostyril- und oxindolderivaten
AT358202B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT351032B (de) Verfahren zur herstellung von neuen chinoxalin- und phenazinderivaten
AT347581B (de) Verfahren zur herstellung von neuen penicillinen und cephalosporinen
AT362060B (de) Verfahren zur herstellung von neuen anti- biotika (a-40104)und derivaten davon
AT362357B (de) Verfahren zur herstellung von neuen imidazol- derivaten und deren metallkomplexen
AT343291B (de) Verfahren zur herstellung von neuen quartaren xanthinylalkyl-nortropinderivaten
AT369735B (de) Verfahren zur herstellung von neuen pyrazolidin-dion-derivaten
AT356813B (de) Verfahren zur herstellung von neuen penicillin- derivaten
AT370105B (de) Verfahren zur herstellung von neuen 1-oxadethiacepham-und -cephem-derivaten
AT373603B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796779A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796979A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT352117B (de) Verfahren zur herstellung von neuen imidazol- derivaten und ihren salzen
AT347449B (de) Verfahren zur herstellung von neuen imidazolderivaten und ihren salzen
ATA613676A (de) Verfahren zur herstellung von teilweise neuen imidazolderivaten und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee